Targeting miR‐126 disrupts maintenance of myelodysplastic syndrome stem and progenitor cells-Reference-Cited by-同舟云学术

Targeting miR‐126 disrupts maintenance of myelodysplastic syndrome stem and progenitor cells

Published:2021-10 Issue:10 Volume:11 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical and Translational Medicine

Author:

Wang Huafeng¹²³⁴,Sun Jie¹²³,Zhang Bin²,Zhao Dandan²,Tong Hongyan¹³,Wu Herman²,Li Xia¹,Luo Yingwan¹,Dong Dan²,Yao Yiyi¹³,McDonald Tinisha²,Stein Anthony S.²,Al Malki Monzr M.²,Pichiorri Flavia²,Carlesso Nadia²,Kuo Ya‐Huei²,Marcucci Guido²,Li Ling²,Jin Jie¹³^ORCID

Affiliation:

1. Department of Hematology the First Affiliated Hospital School of Medicine, Zhejiang University Hangzhou Zhejiang PR China

2. Hematological Malignancies Translational Science Gehr Family Center for Leukemia Research City of Hope Medical Center and Beckman Research Institute Duarte California USA

3. Zhejiang Provincial Key Lab of Hematopoietic Malignancy Zhejiang University Hangzhou Zhejiang PR China

4. Zhejiang Laboratory for Systems & Precision Medicine Zhejiang University Medical Center Hangzhou Zhejiang PR China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Zhejiang Province

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.610

Reference29 articles.